Japan’s cost-effectiveness assessment (CEA) panel has approved a revised handling policy for the CEA system for FY2026, with the health…
HOME > ARCHIVE
ARCHIVE
- REGULATORY NEWS IN BRIEF
July 1, 2002
- Good Initial Market Reactions to Olmesartan: Mr Shoda of Sankyo
July 1, 2002
- Number of ADRs Totals 26,545 in FY2001
July 1, 2002
- Sankyo to Conduct Research with Tularik on GPCR Drug Discovery
June 24, 2002
- Ain Pharmaciez Ties Up with Nice Drug of Nagoya
June 24, 2002
- GSK Strengthening Alliance Strategy in Japan
June 24, 2002
- Korosho Urges National Hospitals to Use More Generics
June 24, 2002
- Toho to Exchange Business with 3 Local Wholesalers
June 24, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
June 24, 2002
- Univ. of Tokyo Introduces SNP Typing System from Olympus
June 24, 2002
- Matsumotokiyoshi to Restart Aggressive Store Opening
June 24, 2002
- WEBSITE NEWS
June 24, 2002
- Sugi Pharmacy Installs Clean Benches in Drugstores
June 24, 2002
- BUSINESS NEWS IN BRIEF
June 24, 2002
- Terumo: Glucose Meter with Voice Guide Function
June 24, 2002
- Kusuri Provervs Reveal Japanese Spirit (11)
June 24, 2002
- J&J Sponsors Seminar on Shunt Intervention
June 24, 2002
- 29 Products Including Zomig RM Added to NHI List
June 24, 2002
- Medtronic, Baxter Present Reports on Products Using Swine Heart Valves
June 24, 2002
- Establishment of Fast-track System Requested Again by FPMAJ: PAL Hearings
June 24, 2002
ページ
The launch of Elevidys has opened the door to gene therapy for DMD, but research into new treatments is already…
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…